Literature DB >> 12245

Specific transplantation tolerance induced by autoimmunization against the individual's own, naturally occurring idiotypic, antigen-binding receptors.

H Binz, H Wigzell.   

Abstract

Serum or urine from normal adult Lewis rats can be shown to contain detectable amounts of idiotypic, antigen-binding receptors with specificity for the major histocompatibility complex locus antigens of the rat, the Ag-B locus antigens. Such purified naturally occurring receptor molecules, be they of T- or B-lymphocyte origin, can be used in a polymerized form to provoke the production of auto-anti-idiotypic antibodies when injected back into normal Lewis rats. As a consequence of this autoimmunity, lymphocytes of these Lewis rats can be shown to be depleted of cells carrying the relevant idiotypic receptors signifying reactivity against a given Ag-B locus-determined antigen(s). This specific lack of idiotypic lymphocytes is manifested as a selective loss of reactivity against the relevant Ag-B-incompatible antigens as measured by graft versus host or MLC reactions. Furthermore, autoimmune Lewis rats display specific transplantation tolerance against the skin grafts from the relevant strain, as demonstrated by specific prolongation of graft survival. A further indication of the specific tolerence state of these rats comes from the highly reduced ability to produce circulating antibodies against the relevant Ag-B antigens. No side effects of these autoimmunization procedures have been noted so far. It would thus seem clear that a prolonged state of specific transplantation tolerance can be achieved via autoimmunization against the individual's naturally occurring idiotypic, antigen-binding receptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12245      PMCID: PMC2190473          DOI: 10.1084/jem.144.6.1438

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

3.  A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells.

Authors:  W L Ford; W Burr; M Simonsen
Journal:  Transplantation       Date:  1970-09       Impact factor: 4.939

4.  Neonatal tolerance induced by antibody against antigen-specific receptor.

Authors:  D S Strayer; H Cosenza; W M Lee; D A Rowley; H Köhler
Journal:  Science       Date:  1974-11-15       Impact factor: 47.728

5.  Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens.

Authors:  T J McKearn; F P Stuart; F W Fitch
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  Biosynthesis of immunoglobulin A (IgA). Secretion and addition of carbohydrate to monomer and polymer forms of a mouse myeloma protein.

Authors:  E Della Corte; R M Parkhouse
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

7.  Specific positive selection of lymphocytes reactive to strong histocompatibility antigens.

Authors:  J C Howard; D B Wilson
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

8.  Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex.

Authors:  W L Ford; S J Simmonds; R C Atkins
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

9.  Studies of idiotypic antibodies. Production and characterization of autoantiidiotypic antisera.

Authors:  L S Rodkey
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

10.  Cell-bound receptors for alloantigens on normal lymphocytes. II. Antialloantibody serum contains specific factors reacting with relevant immunocompetent T lymphocytes.

Authors:  H Binz; J Lindenmann; H Wigzell
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Homeostatic control of immunity by TCR peptide-specific Tregs.

Authors:  Vipin Kumar
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  The role of an anti-idiotype antibody in regulating hapten (azobenzenearsonate)-specific granuloma formation.

Authors:  C H Ginsburg; E Wisniewski; M I Greene
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

3.  Successful cardiac allografts in syngeneic radiation chimeras.

Authors:  J Dittmer; M Bennett
Journal:  Mol Cell Biochem       Date:  1978-11-01       Impact factor: 3.396

Review 4.  Recognition of antigens by T lymphocytes.

Authors:  H Binz; H Wigzell
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

Review 5.  Mechanisms of idiotype suppression: role of anti-idiotype antibody.

Authors:  B S Kim
Journal:  Surv Immunol Res       Date:  1982

6.  Non-specific inhibitory processes of immunological and mitogenic cellular responses.

Authors:  M Liacopoulos; F Lambert; P Liacopoulos
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

7.  Prolongation of survival of rat cardiac allografts by T cell vaccination.

Authors:  O M Shapira; E Mor; T Reshef; R A Pfeffermann; I R Cohen
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.

Authors:  R M Gorczynski; S Macrae
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

9.  A role for self-recognizing T cells in the regulation of antibody-forming and cell-mediated cytotoxic responses in the mouse.

Authors:  R M Gorczynski; M Boulanger
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

10.  Autoregulation of an antibody response via network-induced auto-anti-idiotype.

Authors:  J C Brown; L S Rodkey
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.